NIH launched clinical trial of mRNA Nipah virus vaccine
On Jul. 11, 2022, the National Institute of Allergy and Infectious Diseases (NIAID) launched an early-stage clinical trial…
-
-
Pfizer and BioNTech submitted a variation to EMA for vaccination of children ages 6 months to less than 5 Years with COMIRNATY
On Jul. 8, 2022, Pfizer and BioNTech announced that the companies had submitted a variation to the European…
-
Fourth backyard flock tested positive for highly pathogenic avian influenza in Oregon
On Jul. 8, 2022, the U.S. Department of Agriculture’s Animal and Plant Health Inspection Service confirmed the state’s…
-
Agriculture | Biotechnology | Diagnostics | Infectious Disease | Influenza | USDA | Vaccine | Veterinary
USDA confirmed highly pathogenic Avian influenza in Nevada
On Jul. 8, 2022, the U.S. Department of Agriculture’s Animal and Plant Health Inspection Service (APHIS) confirmed the…
-
Ghana reported first-ever suspected cases of Marburg virus disease
On Jul. 7, 2022, Ghana has announced the preliminary finding of two cases of Marburg virus disease and…
-
European Medicines Agency approved SK bioscience as supplier of Novavax Nuvaxovid COVID-19 vaccine
On Jul. 7, 2022, Novavax announced that the European Commission had approved a variation to allow SK bioscience…
-
Labcorp first national laboratory to offer Mpox test
On Jul. 6, 2022, LabCorp announced that it had begun testing for mpox using the U.S. Centers for…
-
Novavax Nuvaxovid COVID-19 vaccine conditionally authorized in EU for adolescents aged 12 through 17
On Jul. 5, 2022, Novavax announced that the European Commission (EC) had approved the expanded conditional marketing authorization…
-
COVID-19 vaccination activates antibodies targeting parts of virus spike protein shared between coronaviruses
On Jul. 5, 2022, Tgen and Northern Arizona University announced that a research team found that the vaccine…
-
NIH study revealed how immune response triggered by COVID-19 may damage the brain
On Jul. 5, 2022, the National Institutes of Health released a study that described the immune response triggered…
-
The Democratic Republic of the Congo declareed 14th Ebola outbreak over
On Jul. 4, 2022, the Democratic Republic of the Congo declared the end of the Ebola outbreak that…
-
Whole Health School of Medicine to become Alice L. Walton School of Medicine
On Jun. 30, 2022, Alice L. Walton School of Medicine announces the next steps in its development, including…
-
Pfizer announced submission of New Drug Application to the U.S. FDA for PAXLOVID
On Jun. 30 2022, Pfizer announced the submission of a New Drug Application (NDA) to the U.S. Food…
-
Pfizer and BioNTech announced agreement with U.S. Government to provide additional doses of COVID-19 Vaccine
On Jun. 29, 2022, Pfizer and BioNTech announced a new vaccine supply agreement with the U.S. government to…
-
BD launched combination test for COVID-19, Influenza A/B and Respiratory Syncytial Virus
On Jun. 30, 2022, BD (Becton, Dickinson) announced that the BD MAX Respiratory Viral Panel (RVP), a new…
-
Trial of potential universal flu vaccine opened at NIH Clinical Center
On Jun. 28, 2022, the National Institutes of Health (NIH) announced that a Phase 1 clinical trial of…
-
Biotechnology | Cartoons - Original | CDC | COVID-19 | Diagnostics | FDA | Infectious Disease | Medicine | Neurology | NIH | Non-Profit Research | Olfactory | Pharmaceutical | Therapeutics | U.S. Congress | Vaccine
COVID-19 Wheel of Fortune
Play the COVID-19 Wheel of Fortune and see how lucky you are! You have two wheels to choose…
-
Novavax filed supplement to a New Drug submission in Canada for Nuvaxovid COVID-19 vaccine for adolescents
On Jun. 23 2022, Novavax announced the filing of a Supplement to a New Drug Submission with Health…
-
Novavax COVID-19 vaccine Nuvaxovid recommended for expanded conditional marketing authorization in EU for adolescents aged 12 through 17
On Jun. 23 2022, Novavax announced that the Nuvaxovid (NVX-CoV2373) COVID-19 vaccine had been recommended for expanded conditional…
-
Novavax COVID-19 vaccine Nuvaxovid received EUA in Taiwan for use in individuals aged 18 and over
On Jun. 23 2022, Novavax announced that the Taiwan Food and Drug Administration had granted emergency use authorization…
-
BioNTech started construction of first mRNA vaccine manufacturing facility in Africa
On Jun. 23, 2022, BioNTech announced it had has reached the next milestone in the establishment of scalable…
-
Innovation Pharmaceuticals reported Brilacidin inhibited Omicron, Delta, Gamma and Alpha SARS-CoV-2 variants
On Jun. 23, 2022, Innovation Pharmaceuticals reported that Brilacidin, the Company’s defensin-mimetic drug candidate exhibiting broad-spectrum antiviral activity,…
-
U.S. FDA approved Merck’s VAXNEUVANCE for prevention of invasive pneumococcal disease in infants and children
On Jun. 22, 2022, Merck announced that that the U.S. Food and Drug Administration (FDA) had approved an…
-
Biotechnology | COVID-19 | Diagnostics | Disease | Oncology | Vaccine | Women's Health
Anixa Biosciences Announced Publication of Peer-Reviewed Journal Article Highlighting Ovarian Cancer Vaccine Technology
On Jun. 21, 2022, Anixa Biosciences announced the publication of a peer-reviewed journal article in Clinical and Experimental…
-
US Billionaire Launched New Generation Vaccine Manufacturing Plant in South Africa Based on Cancer Immunotherapy
On Jan. 19, 2022, South African-born U.S. biotech billionaire Patrick Soon-Shiong launched a vaccine manufacturing plant in the…
-
Moderna received FDA authorization for EUA of Its COVID-19 vaccine for children 6 months of age and older
On Jun. 17, 2022, the U.S. Food and Drug Administration (FDA) authorized emergency use of the Moderna COVID-19…
-
Pfizer-BioNTech COVID-19 vaccine received FDA Emergency Use Authorization for children 6 months through 4 years of age
On Jun. 17, 2022, Pfizer and BioNTech announced the U.S. Food and Drug Administration (FDA) had granted emergency…
-
Benaroya Research Institute received $11.4 million to explore link between viruses and immune system diseases
On Jun. 17, 2022, Benaroya Research Institute at Virginia Mason (BRI) announced a 5-year, $11.4 million grant from…
-
Oragenics announced publication of positive data for NT-CoV2-1 intranasal COVID-19 vaccine candidate in Scientific Reports
On Jun. 14 2022, Oragenics announced the publication of an article co-authored by Oragenics and collaborators at Inspirevax…
-
Pfizer reported additional data on PAXLOVID supporting New Drug Application submission to U.S. FDA
On Jun. 14 2022, Pfizer reported data from the Phase 2/3 EPIC-SR (Evaluation of Protease Inhibition for COVID-19…
